{
    "1712470843375411513": {
        "author_id": "194037150",
        "created_at": "2023-10-12T14:10:39.000Z",
        "edit_history_tweet_ids": [
            "1712470843375411513"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 172,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.5392,
                    "start": 161,
                    "type": "Organization"
                }
            ],
            "mentions": [
                {
                    "end": 14,
                    "id": "763605661",
                    "start": 0,
                    "username": "dankremnitzer"
                }
            ]
        },
        "id": "1712470843375411513",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 183,
            "like_count": 0,
            "quote_count": 0,
            "reply_count": 2,
            "retweet_count": 0
        },
        "text": "@dankremnitzer Yes, the positive results from an interim analysis met certain pre-specified criteria for stopping the trial early for efficacy.\nBest regards\nBo, Novo Nordisk"
    }
}